Comment on 'Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures'
Drug Saf. 2020 May;43(5):503-505.
doi: 10.1007/s40264-020-00929-0.